Intravenous immunoglobulin therapy for resistant ocular behçet's disease

N. Seider, I. Beiran, J. Scharf, B. Miller

Research output: Contribution to journalArticlepeer-review

Abstract

Aims - The present report was aimed at finding out whether gammaglobulin could have a role in treating ocular Behçet's disease (BD) refractory to accepted medical therapy. Methods - Six eyes of four patients with ocular BD refractory to steroids and cyclosporin A were treated with a course of intravenous gammaglobulin and followed up for their response to treatment. Results - All six eyes of all four patients showed good response to gammaglobulin therapy. Conclusion - Gamma globulin may have a role in treating refractory ocular BD. A wide range of controlled studies with longer follow up is needed to substantiate this impression.

Original languageEnglish
Pages (from-to)1287-1288
Number of pages2
JournalBritish Journal of Ophthalmology
Volume85
Issue number11
DOIs
StatePublished - 2001
Externally publishedYes

ASJC Scopus subject areas

  • Sensory Systems
  • Cellular and Molecular Neuroscience
  • Ophthalmology

Fingerprint

Dive into the research topics of 'Intravenous immunoglobulin therapy for resistant ocular behçet's disease'. Together they form a unique fingerprint.

Cite this